AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:AKBM - NO0010886625 - Common Stock
96.6 NOK
0 (0%)
We assign a fundamental rating of 3 out of 10 to AKBM. AKBM was compared to 63 industry peers in the Food Products industry. Both the profitability and financial health of AKBM have multiple concerns. AKBM is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year AKBM has reported negative net income.
- In the past year AKBM had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.
- AKBM had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- AKBM has a Return On Assets of -8.56%. This is amonst the worse of the industry: AKBM underperforms 85.71% of its industry peers.
- Looking at the Return On Equity, with a value of -22.75%, AKBM is doing worse than 84.13% of the companies in the same industry.
- The Return On Invested Capital of AKBM (2.36%) is worse than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.56% | ||
| ROE | -22.75% | ||
| ROIC | 2.36% |
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AKBM has a Operating Margin of 3.69%. This is comparable to the rest of the industry: AKBM outperforms 44.44% of its industry peers.
- AKBM's Gross Margin of 45.65% is fine compared to the rest of the industry. AKBM outperforms 68.25% of its industry peers.
- In the last couple of years the Gross Margin of AKBM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.69% | ||
| PM (TTM) | N/A | ||
| GM | 45.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
2. Health
2.1 Basic Checks
- AKBM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, AKBM has about the same amount of shares outstanding.
- Compared to 5 years ago, AKBM has about the same amount of shares outstanding.
- The debt/assets ratio for AKBM has been reduced compared to a year ago.
2.2 Solvency
- AKBM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.07, AKBM is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACC0.28
WACC8.52%
2.3 Liquidity
- A Current Ratio of 2.56 indicates that AKBM has no problem at all paying its short term obligations.
- AKBM has a better Current ratio (2.56) than 87.30% of its industry peers.
- AKBM has a Quick Ratio of 1.14. This is a normal value and indicates that AKBM is financially healthy and should not expect problems in meeting its short term obligations.
- AKBM's Quick ratio of 1.14 is fine compared to the rest of the industry. AKBM outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.56 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- The earnings per share for AKBM have decreased strongly by -115.95% in the last year.
- Looking at the last year, AKBM shows a small growth in Revenue. The Revenue has grown by 2.31% in the last year.
- The Revenue has been decreasing by -4.17% on average over the past years.
EPS 1Y (TTM)-115.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)2.31%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%15.21%
3.2 Future
- The Earnings Per Share is expected to grow by 96.03% on average over the next years. This is a very strong growth
- AKBM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.59% yearly.
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AKBM. In the last year negative earnings were reported.
- A Price/Forward Earnings ratio of 39.67 indicates a quite expensive valuation of AKBM.
- AKBM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AKBM is more expensive than 73.02% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, AKBM is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 39.67 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AKBM is valued a bit more expensive than the industry average as 73.02% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.25 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AKBM's earnings are expected to grow with 96.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.56%
EPS Next 3Y96.03%
5. Dividend
5.1 Amount
- No dividends for AKBM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
OSL:AKBM (1/13/2026, 7:00:00 PM)
96.6
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-31 2025-10-31
Earnings (Next)02-12 2026-02-12/amc
Inst Owners5.57%
Inst Owner ChangeN/A
Ins Owners6.14%
Ins Owner ChangeN/A
Market Cap8.47B
Revenue(TTM)265.70M
Net Income(TTM)-34.10M
Analysts77.78
Price Target86.7 (-10.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend43.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-5.62%
Max Revenue beat(2)1.02%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 39.67 | ||
| P/S | 3.16 | ||
| P/FCF | N/A | ||
| P/OCF | 763.49 | ||
| P/B | 5.6 | ||
| P/tB | 28.09 | ||
| EV/EBITDA | 19.25 |
EPS(TTM)-3.76
EYN/A
EPS(NY)2.44
Fwd EY2.52%
FCF(TTM)-1.97
FCFYN/A
OCF(TTM)0.13
OCFY0.13%
SpS30.56
BVpS17.24
TBVpS3.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.56% | ||
| ROE | -22.75% | ||
| ROCE | 3.06% | ||
| ROIC | 2.36% | ||
| ROICexc | 2.5% | ||
| ROICexgc | 4.14% | ||
| OM | 3.69% | ||
| PM (TTM) | N/A | ||
| GM | 45.65% | ||
| FCFM | N/A |
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
F-Score4
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.06 | ||
| Cap/Depr | 42.42% | ||
| Cap/Sales | 6.85% | ||
| Interest Coverage | 0.64 | ||
| Cash Conversion | 2.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.56 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | N/A |
F-Score4
WACC8.52%
ROIC/WACC0.28
Cap/Depr(3y)77.43%
Cap/Depr(5y)88.04%
Cap/Sales(3y)14.31%
Cap/Sales(5y)16.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue 1Y (TTM)2.31%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%15.21%
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
EBIT growth 1Y246.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year170.83%
EBIT Next 3Y67.11%
EBIT Next 5YN/A
FCF growth 1Y14.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.56%
OCF growth 3Y155.79%
OCF growth 5Y-0.17%
AKER BIOMARINE ASA / AKBM.OL FAQ
Can you provide the ChartMill fundamental rating for AKER BIOMARINE ASA?
ChartMill assigns a fundamental rating of 3 / 10 to AKBM.OL.
Can you provide the valuation status for AKER BIOMARINE ASA?
ChartMill assigns a valuation rating of 2 / 10 to AKER BIOMARINE ASA (AKBM.OL). This can be considered as Overvalued.
Can you provide the profitability details for AKER BIOMARINE ASA?
AKER BIOMARINE ASA (AKBM.OL) has a profitability rating of 2 / 10.
How financially healthy is AKER BIOMARINE ASA?
The financial health rating of AKER BIOMARINE ASA (AKBM.OL) is 3 / 10.
What is the earnings growth outlook for AKER BIOMARINE ASA?
The Earnings per Share (EPS) of AKER BIOMARINE ASA (AKBM.OL) is expected to grow by 70% in the next year.